BitPath Holdings To Launch Tokenize Campaign for Over-The-Counter Market, Launches SPV for Qualified Issuers

It is time for small issuers to prepare for the quantum leap to the blockchain to enter digital capital markets that already work today.

BitPath Holdings, Inc. (OTCMKTS:BPTH)

PITTSBURGH, PA, UNITED STATES, September 4, 2026 /EINPresswire.com/ -- BitPath Holdings, Inc. (OTC: BPTH) today announces plans to tokenize equity and debt of issuers trading on the Over-the-Counter Market ("OTCM"). As part of its plan, the Company intends to tokenize its own common stock, preferred equity and convertible debt and that of certain affiliates to allow it to be represented electronically on the blockchain rather than as listed on or filed with OTCM.

BitPath has spent several months analyzing listing requirements on OTCM and compliance issues associated with SEC Rule 15c211 (“Rule 15c211”). We have listed all BitPath financial information and disclosures that are required by OTC Markets and SEC Rule 15c211 on our own website free of charge and without registration required which fulfills the rule's specifications. For weeks, OTC Markets has demanded payment to upload our information to their own systems, indicating they refuse to talk to us until we were a paying customer. It took several weeks to get a formal explanation of their position from their offices, which simply affirmed that OTCM is a paywall monopoly provider of interdealer quotations and information exchange.

Said Vik Grover CEO: "OTC Market’s system and position is obsolete in today's world of blockchain and decentralized finance ("DeFi") and no longer works for small issuers. It is also not in the spirit of Rule 15c211, which already prevents broker dealers from charging fees to run a due diligence process to analyze securities information required by FINRA and the rule of law before allowing dealers to make markets in equities. It is not in our shareholders’ interest to operate under this suffocating framework any longer. If broker dealers cannot charge for a 15c211 process, it makes no sense for OTCM to charge for similar simple due diligence for dealers. Given this setup, OTC Markets is abusing its quasi-government monopoly role as the only OTC interdealer quotation system. Accordingly, we have declined OTCM's payment demands and are going to provide our shareholders, and the broader OTC market, with an alternative to the current regime."

OTC Markets has an estimated $50 billion in equity and debt capitalization trapped in a legacy TradFi paradigm that makes financing operations and growth difficult for some and impossible for most. BitPath believes it is time for all OTC issuers to prepare for the quantum leap to the blockchain and enter digital capital markets that already work today.

To progress to a new model, BitPath intends to establish a special purpose vehicle (“SPV”) to hold securities of OTCM issuers. The SPV, to do business as "Tokenize", will issue tokens that will be backed by the SPV using equity and debt obtained through token issuances to holders. These assets may include minority investments, majority control stakes, convertible debt, preferred stock, and/or other equity linked securities. BitPath intends the token’s tokenomics to include a high % token burn as trading activity occurs on the blockchain, which format has been widely embraced by investors in notable cryptocurrencies such as Hyperliquid (HYPE.X) and Pump.fun (PUMP.X) leading to significant outperformance. Issuers will still have the opportunity to tokenize remaining equity or debt as an individual listing or remain public on OTCM or other. Over time, BitPath believes Tokenize will generate a network effect as stakeholders receive and trade its tokens to unlock stranded value on the OTC.

Given OTC Market’s unwillingness to work with the Company on a compromise solution while market makers perform their own due diligence, BitPath will begin trading on the Expert Market on Tuesday September 8, 2026. The Company is establishing a record date of Friday September 25, 2026 for shareholders for a potential future dividend of Tokenize tokens as a first step in launching its blockchain program for selected issuers on OTCM that provide self-certified financial statements and valid documentation.

As part of Tokenize, the Company is establishing a website to provide the same reporting as provided to OTC Markets in their own format. Although we have already posted our own disclosures and information on our website to satisfy the requirements of Rule 15c211, we believe a centralized information gathering portal, available free of charge without investor login, provides all investors and dealers full transparency and reinforces our commitment to the spirit of Rule 15c211. We will open this portal to other issuers and are in the process of adding them to our growing disclosure network with planned tiered levels of service at a nominal entry-level expense. We welcome dealers to analyze our data and that of future listings to initiate their own due diligence process under Rule 15c211, which they may find superior to and more accurate than existing systems.

About BitPath Holdings, Inc.

BitPath Holdings, Inc. pka Bio-Path Holdings, Inc. (https://www.biopathholdings.com/) is pivoting to cryptocurrency trading and social media investments in the global market. The legacy Company is a pioneer in MRNA based treatments for rare diseases including acute myeloid leukemia (“AML”). Prexigebersen (Liposomal Grb2 antisense), a lead product candidate, is a neutral-charge, liposome-incorporated antisense drug designed to inhibit protein synthesis of Grb2 (growth factor receptor bound protein 2) that has achieved favorable remission outcomes on initial sample populations. The Company has engaged advisors who are actively exploring partnerships, licenses or sale of its biotechnology platform, trials and data.

Vik Grover
BitPath Holdings, Inc.
+1 630-708-0750
email us here
Visit us on social media:
X